Ke kaumaha kaumaha Semaglutide CAS 910463-68-2
wehewehe
ʻO Semaglutide (910463-68-2) kahi lāʻau anti-diabetic i kūʻai ʻia ma lalo o nā inoa inoa e like me Ozempic, Wegovy, a me Rybelsus.Hoʻohana ʻia ia e mālama i ka maʻi diabetes type 2 a mālama i ke kaumaha mau.Hoʻohana like ka lāʻau lapaʻau me ke kanaka glucagon-like peptide-1 (GLP-1) ma o ka hoʻonui ʻana i ka huna ʻana o ka insulin, e alakaʻi ana i ka hoʻomaikaʻi ʻana i ke kō.Hoʻokaʻawale ʻia ia ma ke ʻano he metered subcutaneous injection i loko o kahi peni i hoʻopiha ʻia, a i ʻole he ʻano waha.ʻO kekahi o kāna mau mea maikaʻi ma mua o nā lāʻau antidiabetic ʻē aʻe he lōʻihi ka lōʻihi o ka hana, no laila, hoʻokahi wale nō hoʻokahi pule i lawa.
Hoʻohana
Hoʻohana ʻia ʻo Semaglutide e hoʻokele i ka maʻi maʻi type 2 me nā loli o ke ʻano o ke ola, e like me nā mea ʻai a me ka hoʻonui ʻana i ka hana kino.Hoʻohana pū ia ma ka hoʻolohi ʻana i ka neʻe ʻana o ka meaʻai ma ka ʻōpū a hiki ke hoʻemi i ka ʻai a hoʻemi i ke kaumaha.ʻAʻole i paʻi ʻia nā hōʻike o ka hepatotoxicity i pili i ka semaglutide therapy.



Mechanism o ka hana
ʻO Semaglutide kahi glucagon-like peptide-1 receptor agonist.Hoʻonui ia i ka hana ʻana o ka insulin, kahi hormone e hoʻohaʻahaʻa i ke kiʻekiʻe o ke kō koko.ʻIke ʻia hoʻi ia e hoʻonui i ka ulu ʻana o nā cell β i ka pancreas, ʻo ia nā wahi o ka hana ʻana o ka insulin.Kāohi pū ia i ka glucagon, ʻo ia ka hormone e hoʻonui ai i ke kō koko.Hoʻemi ia i ka ʻai ʻana ma o ka hoʻohaʻahaʻa ʻana i ka ʻai a hoʻolohi i ka ʻai ʻana i ka ʻōpū.Ma kēia ʻano e hoʻemi ai i ka momona o ke kino.
Hana Ola
ʻO Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), he glucagon-like peptide 1 (GLP-1) analogue lōʻihi, he agonist receptor GLP-1 me ka hiki ke mālama i ka maʻi diabetes type 2. (T2DM).
Puke a me ka lawe ʻana


